Suggestions
Ronald Piervincenzi
CEO, U.S. Pharmacopeia (USP)
Ronald T. Piervincenzi, Ph.D., is the Chief Executive Officer of the United States Pharmacopeia (USP), a position he has held since February 2014. Under his leadership, USP has focused on enhancing the quality of medicines and healthcare products through innovative scientific initiatives and modernized operations. He oversees a global staff of over 1,400 across various locations, including the United States, Brazil, China, Ghana, and India.12
Background and Education: Dr. Piervincenzi has over 20 years of experience in the pharmaceutical industry, with a strong foundation in research and business strategy. Prior to joining USP, he was Vice President of Development Sciences at Biogen Idec, where he initiated programs in personalized medicine for multiple sclerosis treatment. He also spent over 12 years at McKinsey & Company as a partner, where he led global efforts in drug safety and regulatory services.125
He holds a Bachelor of Engineering degree in Bioengineering from Hofstra University and both a Master’s and Ph.D. in Biomedical Engineering from Duke University.45
Contributions to USP: During his tenure at USP, Dr. Piervincenzi has spearheaded several key initiatives aimed at improving public health and ensuring the availability of quality medicines worldwide. His efforts have included launching new science in digital medicine and advanced biologics, as well as establishing training institutes to enhance stakeholder engagement.136 He is also involved in global public health initiatives across various countries.2
In addition to his role at USP, Dr. Piervincenzi serves on the board of Project HOPE, where he contributes to addressing health inequities globally.5 His leadership has been instrumental in maintaining USP's reputation as a leader in setting quality standards since its founding in 1820.12
Highlights
Volunteer Opportunity, Board of Directors
Join this unique volunteer board, comprised of US Pharmacopeia, Pharmatech Associates, a USP company and external leadership to provide invaluable insights to guide Pharamatech’s long-term growth strategy and trajectory, while providing near-term insights and connections to support continued growth in the biologics drug development and manufacturing space.
How will you bring value?
- C-Suite level professionals within Biotechnology contributing deep insights, strengthening Pharmatech’s thought leadership
- Enhancing ability to target proper customer profiles in Biologics, ideally in the Monoclonal Antibody space
#womeninscience
#diversityinstem
https://lnkd.in/e86CUDw9
